Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections-Reference-Cited by-同舟云学术

Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections

Published:2002-02 Issue:2 Volume:19 Page:95-103
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Naber Kurt G.,Savov Orlin,Salmen Hans C.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference48 articles.

1. Nosocomial urinary tract infections;Stamm,1992

2. Surveillance of nosocomial infections;Haley,1992

3. Management of bacterial urinary tract infections in adults;Hatton;Ann. Pharmacother.,1994

4. DMSA renal scans in adults with acute pyelonephritis;Bailey;Clin. Nephrol.,1996

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Piperacillin-tazobactam: prospects for use in real-world practice;Real-World Data & Evidence;2023-10-13

2. Piperacillin/tazobactam versus carbapenems in patients with severe bacterial infections: A systematic review with meta‐analysis;Acta Anaesthesiologica Scandinavica;2023-03-28

3. AAUS guideline for acute uncomplicated pyelonephritis;Journal of Infection and Chemotherapy;2022-08

4. Antibacterial data synthesis challenges: a systematic review of treatments for complicated Gram-negative urinary tract infections;Journal of Comparative Effectiveness Research;2021-12

5. Carbapenem-alternative strategies for complicated urinary tract infections: A systematic review of randomized controlled trials;Journal of Infection;2020-10